Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis

By Mease Philip J  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 11, 2005-11 ,pp. : 1491-1504

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF-α Properties of New 9-Benzyladenine Derivatives with Selective Phosphodiesterase-4- Inhibiting Properties

By Reimund J-M.   Raboisson P.   Pinna G.   Lugnier C.   Bourguignon J-J.   Muller C.D.  

Biochemical and Biophysical Research Communications, Vol. 288, Iss. 2, 2001-10 ,pp. : 427-434

Elsevier

Access to resources Recommend Favorite

Adalimumab for the treatment of severe psoriasis and psoriatic arthritis

By Papoutsaki Marina   Costanzo Antonio   Chimenti Maria-Sole   Chimenti Sergio  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 3, 2008-03 ,pp. : 363-370

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis

By Saraceno Rosita  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1325-1334

Informa Healthcare

Access to resources Recommend Favorite

Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist

By Wong Vicky Kwan   Lebwohl Mark G  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 11, 2005-11 ,pp. : 1505-1513

Informa Healthcare

Access to resources Recommend Favorite